The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: A randomized controlled trial

Preventive Medicine

Volumn 68, Issue , 2014, Pages 62-70

  Holtyn, August F ^a   Koffarnus, Mikhail N ^b   DeFulio, Anthony ^a   Sigurdsson, Sigurdur O ^a,c   Strain, Eric C ^a   Schwartz, Robert P ^d   Leoutsakos, Jeannie Marie S ^a   Silverman, Kenneth ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA TECH CARILION SCHOOL OF MEDICINE   (United States)

^c FLORIDA INSTITUTE OF TECHNOLOGY   (United States)

^d FRIENDS RESEARCH INSTITUTE   (United States)

Author keywords

Cocaine; Contingency management; Employment; Financial incentives; Injection drug use; Methadone; Opiate; Out of treatment injection drug user

Indexed keywords

COCAINE; METHADONE; OPIATE; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG WITHDRAWAL; EMPLOYMENT; FEMALE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; OPIATE ADDICTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REINFORCEMENT; UNITED STATES; URINALYSIS; WORKPLACE; COCAINE-RELATED DISORDERS; HEALTH BEHAVIOR; INTERVIEW; MARYLAND; MOTIVATION; OPIOID-RELATED DISORDERS; PSYCHOLOGY; SUBSTANCE ABUSE; TEACHING HOSPITAL; TREATMENT OUTCOME; URINE;

ANALGESICS, OPIOID; BALTIMORE; COCAINE-RELATED DISORDERS; EMPLOYMENT; HEALTH BEHAVIOR; HOSPITALS, TEACHING; HUMANS; INTERVIEWS AS TOPIC; METHADONE; MOTIVATION; OPIOID-RELATED DISORDERS; REINFORCEMENT (PSYCHOLOGY); SUBSTANCE ABUSE DETECTION; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME; WORKPLACE;

EID: 84921899350     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2014.02.021     Document Type: Article

References (64)

1. Abdala N., Stephens P.C., Griffith B.P., Heimer R. Survival of HIV-1 in syringes. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1999, 20:73-80.
2. Al-Tayyib A.A., Koester S. Injection drug users' experience with and attitudes toward methadone clinics in Denver, CO. J. Subst. Abuse Treat. 2011, 41:30-36.
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Washington, DC. Fourth edition.
4. Ball J.C., Lange W.R., Myers C.P., Friedman S.R. Reducing the risk of AIDS through methadone maintenance treatment. J. Health Soc. Behav. 1988, 29:214-226.
5. Barthwell A., Senay E., Marks R., White R. Patients successfully maintained with methadone escaped human immunodeficiency virus infection. Arch. Gen. Psychiatry 1989, 46:957-958.
6. Booth R.E., Crowley T.J., Zhang Y. Substance abuse treatment entry, retention and effectiveness: out-of-treatment opiate injection drug users. Drug Alcohol Depend. 1996, 42:11-20.
7. Booth R.E., Kwiatkowski C., Iguchi M.Y., Pinto F., John D. Facilitating treatment entry among out-of-treatment injection drug users. Public Health Rep. 1998, 113:116-128. (Washington, D.C.: 1974).
8. Booth R.E., Corsi K.F., Mikulich S.K. Improving entry to methadone maintenance among out-of-treatment injection drug users. J. Subst. Abuse Treat. 2003, 24:305-311.
9. Booth R.E., Corsi K.F., Mikulich-Gilbertson S.K. Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug Alcohol Depend. 2004, 74:177-185.
10. Bux D.A., Iguchi M.Y., Lidz V., Baxter R.C., Platt J.J. Participation in an outreach based coupon distribution program for free methadone detoxification. Hosp. Community Psychiatry 1993, 44:1066-1072.
11. Caplehorn J.R., Ross M.W. Methadone maintenance and the likelihood of risky needle-sharing. Int. J. Addict. 1995, 30:685-698.
12. Compton W.M., Cottler L.B., Dorsey K.B., Spitznagel E.L., Mager D.E. Comparing assessments of DSM-IV substance dependence disorders using CIDI-SAM and SCAN. Drug Alcohol Depend. 1996, 41:179-187.
13. DeFulio A., Donlin W.D., Wong C.J., Silverman K. Employment-based abstinence reinforcement as a maintenance intervention for the treatment of cocaine dependence: a randomized controlled trial. Addiction 2009, 104:1530-1538.
14. DeFulio A., Everly J.J., Leoutsakos J.M.S., et al. Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: a randomized controlled trial. Drug Alcohol Depend. 2012, 120:48-54.
15. Degenhardt L., Mathers B., Guarinieri M., et al. Meth/amphetamine use and associated HIV: implications for global policy and public health. Int. J. Drug Policy 2010, 21:347-358.
16. Dennis M., Scott C.K. Managing addiction as a chronic condition. Addict. Sci. Clin. Pract. 2007, 4:45-55.
17. Dennis M.L., Ingram P.W., Burks M.E., Rachal J.V. Effectiveness of streamlined admissions to methadone treatment: a simplified time-series analysis. J. Psychoactive Drugs 1994, 26:207-216.
18. Donlin W.D., Knealing T.W., Needham M., Wong C.J., Silverman K. Attendance rates in a workplace predict subsequent outcome of employment-based reinforcement of cocaine abstinence in methadone patients. J. Appl. Behav. Anal. 2008, 41:499-516.
19. Dunn K.E., Defulio A., Everly J.J., et al. Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users. Exp. Clin. Psychopharmacol. 2013, 21:74-83.
20. Everly J.J., DeFulio A., Koffarnus M.N., et al. Employment-based reinforcement of adherence to depot naltrexone in unemployed opioid-dependence adults: a randomized controlled trial. Addiction 2011, 106:1309-1318.
21. Farrell M., Gowing L., Marsden J., Ling W., Ali R. Effectiveness of drug dependence treatment in HIV prevention. Int. J. Drug Policy 2005, 16:67-75.
22. Friedman S.R., Jose B., Deren S., Des Jarlais D.C., Neaiqus A. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The National AIDS Research Consortium. Am. J. Epidemiol. 1995, 142:864-874.
23. Galai N., Safaeian M., Vlahov D., Bolotin A., Celentano D.D. Longitudinal patterns of drug injection behavior in the ALIVE study cohort, 1988-2000: description and determinants. Am. J. Epidemiol. 2003, 158:695-704.
24. Grella C.E., Anglin M.D., Wugalter S.E. Patterns and predictors of cocaine and crack use by clients in standard and enhanced methadone maintenance treatment. Am. J. Drug Alcohol Abuse 1997, 23:15-42.
25. Hartel D.M., Schoenbaum E.E., Selwyn P.A., Kline J., Davenny K., Klein R.S., Friedland G.H. Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am. J. Public Health 1995, 85:83-88.
26. Higgins S.T., Delaney D.D., Budney A.J., et al. A behavioral approach to achieving initial cocaine abstinence. Am. J. Psychiatry 1991, 148:1218-1224.
27. Higgins S.T., Badger G.J., Budney A.J. Initial abstinence and success in achieving longer term cocaine abstinence. Exp. Clin. Psychopharmacol. 2000, 8:377-386.
28. Higgins S.T., Wong C.J., Badger G.J., Ogden D.E., Dantona R.L. Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1year of follow-up. J. Consult. Clin. Psychol. 2000, 68:64-72.
29. Hser Y.I., Hoffman V., Grella C.E., Anglin M.D. A 33-year follow-up of narcotics addicts. Arch. Gen. Psychiatry 2001, 58:503-508.
30. Hser Y.I., Huang D., Chou C.P., Anglin M.D. Trajectories of heroin addiction: growth mixture modeling results based on a 33-year outcome study. Eval. Rev. 2007, 31:548-563.
31. Hser Y.I., Huang D., Brecht M.L., Li L., Evans E. Contrasting trajectories of heroin, cocaine, and methamphetamine use. J. Addict. Dis. 2008, 27:13-21.
32. Hubbard R.L., Craddock S.G., Flynn P.M., Anderson J., Etheridge R.M. Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol. Addict. Behav. 1997, 11:261-278.
33. iLearn (Retrieved October 4, 2013, from). http://www.ilearn.com/web/ipass.html.
34. Jackson J.F., Rotkiewicz L.G., Quinones M.A., Passannante M.R. A coupon program-drug treatment and AIDS education. Int. J. Addict. 1989, 24:1035-1051.
35. Kidorf M., King V.L., Neufeld K., Peirce J., Kolodner K., Brooner R.K. Improving substance abuse treatment enrollment in community syringe exchangers. Addiction 2009, 104:786-795.
36. Kidorf M., King V.L., Gandotra N., Kolodner K., Brooner R.K. Improving treatment enrollment and re-enrollment rates of syringe exchangers: 12-month outcomes. Drug Alcohol Depend. 2012, 124:162-166.
37. Kleber H.D. Methadone maintenance 4 decades later: thousands of lives saved but still controversial. JAMA 2008, 300:2303-2305.
38. Koffarnus M.N., Wong C.J., Fingerhood M., Svikis D.S., Bigelow G.E., Silverman K. Monetary incentives to reinforce engagement and achievement in a job-skills training program for homeless, unemployed adults. J. Appl. Behav. Anal. 2013, 46:582-591.
39. Kwiatkowski C.F., Booth R.E. Methadone maintenance as HIV risk reduction with street-recruited injecting drug users. J. Acquir. Immune Defic. Syndr. 2001, 26:483-489.
40. Lussier J.P., Heil S.H., Mongeon J.A., Badger G.J., Higgins S.T. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006, 101:192-203.
41. Magura S., Kang S.Y., Nwakeze P.C., Demsky S. Temporal patterns of heroin and cocaine use among methadone patients. Subst. Use Misuse 1998, 33:2441-2467.
42. Mathers B., Degenhardt L., Phillips B. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008, 372:1733-1745.
43. McLellan A.T., Luborsky L., Cacciola J., et al. New data from the Addiction Severity Index. Reliability and validity in three centers. J. Nerv. Ment. Dis. 1985, 173:412-423.
44. McLellan A.T., Lewis D.C., O'Brien C.P., Kleber H.D. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000, 284:1689-1695.
45. Mejta C.L., Bokos P.J., Mickenberg J., Maslar M.E., Senay E. Improving substance abuse treatment access and retention using a case management approach. J. Drug Issues 1997, 27:329-340.
46. Metzger D.S., Woody G.E., McLellan A.T., et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J. Acquir. Immune Defic. Syndr. 1993, 6:1049-1056.
47. Navaline H., Snider E., Petro C., et al. Automated version of the Risk Assessment Battery (RAB): enhancing the assessment of risk behaviors. AIDS Res. Hum. Retrovir. 1994, 10:S281-S283.
48. Peterson J.A., Schwartz R.P., Mitchell S.G., et al. Why don't out-of-treatment individuals enter methadone treatment programmes?. Int. J. Drug Policy 2010, 21:36-42.
49. Robles R.R., Reyes J.C., Colon H.M., et al. Effects of combined counseling and case management to reduce HIV risk behaviors among Hispanic drug injectors in Puerto Rico: a randomized control study. J. Subst. Abuse Treat. 2004, 27:145-152.
50. Rosenberg M. Society and the Adolescent Self-image 1989, Wesleyan University Press, Middletown, CT. Revised edition.
51. Schwartz R.P., Highfield D.A., Jaffe J.H., et al. A randomized controlled trial of interim methadone maintenance. Arch. Gen. Psychiatry 2006, 63:102-109.
52. Schwartz R.P., Kelly S.M., O'Grady K.E., et al. Attitudes toward buprenorphine and methadone among opioid dependent individuals. Am. J. Addict. 2008, 17:396-401.
53. Silverman K. Exploring the limits and utility of operant conditioning in the treatment of drug addiction. Behav. Anal. 2004, 27:209-230.
54. Silverman K., Svikis D., Robles E., Stitzer M.L., Bigelow G.E. A reinforcement-based therapeutic workplace for the treatment of drug abuse: six-month abstinence outcomes. Exp. Clin. Psychopharmacol. 2001, 9:14-23.
55. Silverman K., Svikis D., Wong C.J., Hampton J., Stitzer M.L., Bigelow G.E. A reinforcement-based therapeutic workplace for the treatment of drug abuse: three-year abstinence outcomes. Exp. Clin. Psychopharmacol. 2002, 10:228-240.
56. Silverman K., Wong C.J., Needham M., et al. A randomized trial of employment-based reinforcement of cocaine abstinence in injection drug users. J. Appl. Behav. Anal. 2007, 40:387-410.
57. Silverman K., DeFulio A., Sigurdsson S.O. Maintenance of reinforcement to address the chronic nature of drug addiction. Prev. Med. 2012, 55:S46-S53.
58. Sorensen J.L., Costatini M.F., Wall T.L., Gibson D.R. Coupons attract high-risk untreated heroin users into detoxification. Drug Alcohol Depend. 1993, 31:247-252.
59. Strathdee S.A., Ricketts E.P., Huettner S., et al. Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: results from a community based behavioral intervention trial. Drug Alcohol Depend. 2006, 83:225-232.
60. Sullivan L.E., Metzger D.S., Fudala P.J., Fiellin D.A. Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. Addiction 2005, 100:150-158.
61. Vlahov D., Roberston A.M., Strathdee S.A. HIV prevention among injection drug users in resource-limited settings. Clin. Infect. Dis. 2010, 50:S114-S121.
62. Wilkinson G.S. WRAT-3: Wide Range Achievement Test Administration Manual 1993, Wide Range, Inc., Wilmington, DE.
63. Yancovitz S.R., Des Jarlais D.C., Peyser N.P., et al. A randomized trial of an interim methadone maintenance clinic. Am. J. Public Health 1991, 81:1185-1191.
64. Zaller N.D., Bazazi A.R., Velazquez L., Rich J.D. Attitudes toward methadone among out-of-treatment minority injection drug users: implications for health disparities. Int. J. Environ. Res. Public Health 2009, 6:787-797.